Sanofi-Pasteur, the world’s biggest vaccine company, has signed a contract with the University of California, San Diego, to develop “an immunological approach to acne prevention and treatment”.
“More than 85 per cent of teenagers and over 40 million people in the United States alone are suffering this disease” and many adults have it too, says Chun-Ming Huang, head of the lab at the centre of the deal.
Yet there is little effective treatment, says Huang. “This collaboration will make our dreams of acne vaccines for the public come true earlier”
For more information on this story click here
talkhealth
This is the talkhealth blog spot, where we post on a wide range of health conditions, topics, issues and concerns. We post when we see something that we believe is of interest to our visitors. Our posts do not reflect any particular view or standpoint of talkhealth, but are merely to raise attention and awareness.
Join with Google
Join with Facebook
This is an issue I must find more information about, thanks for the post.
on October 6, 2011 at 3:45 pm Yong